Close Menu
  • FDA
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • ESMO
    • MOASC
    • Upcoming Oncology Conferences
  • Cancers
    • Breast Cancer
    • Prostate Cancer Treatment
    • Lung Cancer Treatment
    • Gastrointestinal Cancer Treatment
    • Melanoma Skin Cancer Treatment
    • Non-Hodgkin Lymphoma
    • Kidney
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Liver
    • Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • About
  • Contact
  • Advertise
    • Advertising and Services – Media Kit 2025 – OncologyTube.com
    • Oncology Press Release Distribution
Advertisement
X (Twitter) LinkedIn Facebook
X (Twitter) LinkedIn Facebook YouTube
OncologyTube
  • FDA
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • ESMO
    • MOASC
    • Upcoming Oncology Conferences
  • Cancers
    • Breast Cancer
    • Prostate Cancer Treatment
    • Lung Cancer Treatment
    • Gastrointestinal Cancer Treatment
    • Melanoma Skin Cancer Treatment
    • Non-Hodgkin Lymphoma
    • Kidney
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Liver
    • Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • About
  • Contact
  • Advertise
    • Advertising and Services – Media Kit 2025 – OncologyTube.com
    • Oncology Press Release Distribution
Subscribe
OncologyTube
[the_ad id="32629"]
Home » Page 6

HPV Advances – Guiding Post-Operative Radiation by Surgery

Head and Neck 1 Min Read

We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…

HPV Advances – Identifying Candidates for De-Escalation

Head and Neck 1 Min Read

We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…

Clinical Trials Experiences Through Storytelling – Melinda Bachini – C-Day

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Clinical Trials Experiences Through Storytelling – Melinda Bachini – The Miracle of a Clinical Trial

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Clinical Trial Experiences Through Storytelling – Melinda Bachini – Lifting the Barriers

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Clinical Trial Experiences Through Storytelling – Melinda Bachini – So Grateful for Time

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Clinical Trials Experiences Through Storytelling – Jared Bigman – Diagnosed Young, Treatment Options

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Clinical Trials Experiences Through Storytelling – Jared Bigman – Life Changes, Keep on Going

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Clinical Trials Experiences Through Storytelling – Jared Bigman – Insurance, Benefits, Communication

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Clinical Trials Experiences Through Storytelling – Jared Bigman – Choices, Finding the Right Trial

Patient Resources 1 Min Read

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to…

Blood Cancer Video Library – Immunotherapy Treatments for B-Cell Non-Hodgkin’s Lymphoma: CAR-T Cells

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Associate Professor of Hematology and Medical Oncology, Associate Professor of…

Blood Cancer Video Library – Immunotherapy Treatments B-Cell Non-Hodgkin’s: Bispecific Antibodies

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Associate Professor of Hematology and Medical Oncology, Associate Professor of…

Blood Cancer Video Library – Treatment Options for Relapsed Diffuse Large B-Cell Lymphoma

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC…

Blood Cancer Video Library – CAR T-Cell Therapy Patients with Relapsed Diffuse Large B-Cell Lymphoma

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC…

Blood Cancer Video Library – CAR T-Cell Therapy Side Effects

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC…

Blood Cancer Video Library – Emerging Types of CAR T-Cell Therapy

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, Dr. Aaron Goodman, Associate Professor of Medicine Hematology/Oncology, at Moores Cancer Center, UC…

Blood Cancer Video Library – Cancer Care in HIV-Infected Patients

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, joining us is Dr. Marco Ruiz, M.D., MPH, FACP, FIDSA, Chief of HIV…

Blood Cancer Video Library – Cancer Care in Senior Patients

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, joining us is Dr. Marco Ruiz, M.D., MPH, FACP, FIDSA, Chief of HIV…

Blood Cancer Video Library – Closing the Gap in Cancer Care for Ethnic Minorities

Lymphoma 1 Min Read

For the GRACE Blood Cancer Video Library, joining us is Dr. Marco Ruiz, M.D., MPH, FACP, FIDSA, Chief of HIV…

Bladder Cancer Video Library – What is a Biomarker?

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – PD-L1 in Metastatic Bladder Cancer

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Tumor Mutation Burden and Neoantigens

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Tumor Infiltrating Lymphocytes and Tumor Associated Macrophages

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Microbiomes and Genomics: The Effect on Immunotherapy

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Circulating Tumor DNA

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Brown – Artificial Neural Networks in Bladder Cancer Treatment

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Treatment Paradigm for Patients with Bladder Cancer

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Platinum Ineligibility for Patients with Bladder Cancer

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Keynote 361: Pembrolizumab Compared to GemCarbo

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – The Evolution of First Line Therapy in Cisplatin-Ineligible Patients

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

Bladder Cancer Video Library – Adjuvant Pembrolizumab: The Ambassador Trial

Bladder 1 Min Read

We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…

2021-22 PEA Program High Quality Decisions – Kwon – Treatment Options

Prostate Cancer Treatment 1 Min Read

Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video…

2021-22 PEA Program High-Quality Decisions – Kwon – Knowing My Prostate Cancer

Prostate Cancer Treatment 1 Min Read

Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video…

2021-22 PEA Program High Quality Decisions – Kwon – Delaying Treatment vs. Starting Immediately

Prostate Cancer Treatment 1 Min Read

Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video…

Lung Cancer Video Library – Immunotherapy for Patients with Driver Mutation

Non-Small Cell Lung Cancer 2 Mins Read

We are excited to bring new and updated information to share through our Lung Cancer Video Library. For this video…

EHA 2022 (European Hematology Association): Conference Coverage

Conference Coverage 40 Mins Read

EHA 2022 Conference Coverage EHA 2022 (European Hematology Association) Conference Coverage – Synopsis Below EHA 2022 (European Hematology Association) Phase…

Module #1: Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer

Prostate Cancer Treatment 1 Min Read

This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the…

Module #2: Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer

Prostate Cancer Treatment 1 Min Read

This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the…

Individualizing Prostate Cancer Treatment: Special Considerations for Gay and Bisexual Men

Prostate Cancer Treatment 1 Min Read

This educational activity features a panel consisting of an oncologist as well as leading experts (a urologist and a researcher)…

Case #3: New Possibilities for Maintenance Therapy in AML

Acute Lymphoblastic Leukemia 1 Min Read

A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…

Case #1: New Possibilities for Maintenance Therapy in AML

Acute Lymphoblastic Leukemia 1 Min Read

A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…

Case #2: New Possibilities for Maintenance Therapy in AML

Acute Lymphoblastic Leukemia 1 Min Read

A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…

Case #2: New Possibilities for Maintenance Therapy in AML

Acute Lymphoblastic Leukemia 1 Min Read

A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…

Case #1: New Possibilities for Maintenance Therapy in AML

Acute Myelogenous Leukemia 1 Min Read

A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…

Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer- and Chemotherapy-Induced Anemia

Other 1 Min Read

This quick, comprehensive video reviews the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath…

Pathways to Transfusion Independence & Reduced Health Complications: Advances for Lower-Risk MDS

Other 1 Min Read

In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience…

Pathways to Transfusion Independence & Reduced Health Complications: Advances for Lower-Risk MDS

Other 1 Min Read

In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience…

Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2

Breast Cancer 1 Min Read

Are you involved in treating patients with triple negative breast cancer (TNBC)? The emergence of TROP2-directed antibody drug conjugate (ADC)…

Myelofibrosis Danazol vs Momelotinib a JAK inhibitor

Business Management 4 Mins Read

Myelofibrosis Danazol vs Momelotinib a JAK inhibitor H2 title H3 title 1st Thing You Will Learn In This Article 3rd…

Disparities in Immunotherapy Cancer Care

Immunotherapy 1 Min Read

Follow real-world patients on their cancer journeys as they and their multidisciplinary clinical teams navigate barriers to receiving treatment with…

Pembrolizumab + Adoptive Cell Therapy Melanoma with T-Cell data

Other 6 Mins Read

Pembrolizumab + Adoptive Cell Therapy Melanoma with T-Cell data. Tumor-infiltrating lymphocytes, and tumor-infiltrating lymphocytes recognize tumor antigens. We looked at…

Colorectal Cancer Mortality if Diagnosed Before 50

Colorectal 5 Mins Read

We completed a geospatial epidemiological study, examining colorectal cancer mortality among those diagnosed before the age of 50. And this…

I-SPY2 HER2+ and HER2- Precisely ID’d with 53 Gene Signatures

Breast Cancer 8 Mins Read

This study led us to the discovery of 53 gene signatures called IMPRINT and with the data we used to…

Is Hematopoietic Stem Cell the only APDS Option?

Other 10 Mins Read

APDS or activated PI3KK delta syndrome is a relatively new disease that was only fully characterized in 2013. It is…

Bevacizumab FOLFOXIRI – Atezolizumab Metastatic Colorectal Cancer

Colorectal 5 Mins Read

In this interview, I will present the results of a translational analysis of the Italian drug study. AtezoTRIBE is a…

BRCA1, BRCA2 or PALB2 in pancreatic cancer.

Pancreatic 6 Mins Read

This study that we presented at ASCO is titled a descriptive study on the treatment and outcomes of patients with…

Multiple Myeloma Medication: MM6 Trial with Dexamethasone

Multiple Myeloma 5 Mins Read

The MM6 trial marks a significant advancement in multiple myeloma treatment, specifically for relapsed or refractory multiple myeloma (RRMM). For…

Article: Transcript: What Is ECOG-ACRIN EA2142? And Why Should You Care? – Jennifer R. Eads, MD @PennMedicine #ASCO22 #OncoTwitter

Gastrointestinal Cancer Treatment 5 Mins Read

  Article: Transcript: Question – Please Tell Us About The EA 2142 Trial   So, at ASCO 2022 this year…

Transcript Anal Cancer in HIV patients, ANCHOR Study Results

Gastrointestinal Cancer Treatment 15 Mins Read

  Well this is a study to answer a very basic question that people have who are taking care of…

Article: Transcript: How Immune Checkpoint Inhibitors Get Scored With 27-gene IO – Matthew Varga, PhD @OncocyteCorp #ASCO22 #OncoTwitter

Gastrointestinal Cancer Treatment 7 Mins Read

  Article: Transcript: Question – Please Tell Us About The 27-gene IO Score Thanks, Stephanie, I appreciate the invitation to…

Article: Transcript: CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions – Daniel R. Carrizosa, MD @DCarrizosaMD @AtriumHealth #ASCO22 #OncoTwitter

Other 4 Mins Read

  CRESTONE was an international multi-site study looking at the use of Seribantumab a monoclonal antibody to HER3 in the…

Audio: What Is ECOG-ACRIN EA2142? And Why Should You Care? – Jennifer R. Eads, MD @PennMedicine #ASCO22 #OncoTwitter

Gastrointestinal Cancer Treatment 2 Mins Read

Audio: So, at ASCO 2022 this year I had the opportunity to present the results of the EA 2142 clinical…

Platinum Chemotherapy vs TemozolomideCapecitabine for Advanced GEPNENs: ECOG-ACRIN EA2142 Results Jennifer Eads MD

Gastrointestinal Cancer Treatment 11 Mins Read

Platinum Chemotherapy: vs. Temozolomide/Capecitabine for Advanced GEPNENs: ECOG-ACRIN EA2142 Results Jennifer Eads MD By Jennifer Eads, MD So, at ASCO…

Podcast Anal Cancer in HIV patients, ANCHOR Study Results

Gastrointestinal Cancer Treatment 16 Mins Read

Well this is a study to answer a very basic question that people have who are taking care of individuals…

Anal Cancer in HIV patients, ANCHOR Study Results

Gastrointestinal Cancer Treatment 16 Mins Read

Well this is a study to answer a very basic question that people have who are taking care of individuals…

Audio: How Immune Checkpoint Inhibitors Get Scored With 27-gene IO – Matthew Varga, PhD @OncocyteCorp #ASCO22 #OncoTwitter

Gastrointestinal Cancer Treatment 3 Mins Read

Audio: Thanks, Stephanie, I appreciate the invitation to interview with you today so I’m going to talk about how the…

DetermaIO algorithm and qPCR assay

Gastrointestinal Cancer Treatment 10 Mins Read

DetermaIO algorithm and qPCR assay are used to show an association with molecular features of gastric cancer that have also…

Audio: CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions – Daniel R. Carrizosa, MD @DCarrizosaMD @AtriumHealth #ASCO22 #OncoTwitter

Other 7 Mins Read

CRESTONE was an international multi-site study looking at the use of Seribantumab a monoclonal antibody to HER3 in the treatment…

HER3 and Seribantumab and the CRESTONE data

Other 5 Mins Read

CRESTONE was an international multi-site study looking at the use of Seribantumab a monoclonal antibody to HER3 in the treatment…

Audio: Video: What are the AMEERA-6 Results? A breast cancer study evaluating Amcenestrant or Tamoxifen – David Cameron, MD @EdinburghUni #ASCO22 #OncoTwitter

Breast Cancer 9 Mins Read

So, I’m talking about the AMEERA-6, which is a trial which is currently ongoing. So, we don’t yet have any…

Tamoxifen and the AMEERA-6 Results

Breast Cancer 9 Mins Read

So, I’m talking about the AMEERA-6, which is a trial which is currently ongoing. So, we don’t yet have any…

Article: Transcript: What are the AMEERA-6 Results? A breast cancer study evaluating Amcenestrant or Tamoxifen – David Cameron, MD @EdinburghUni #ASCO22 #OncoTwitter

Breast Cancer 7 Mins Read

  Article: Transcript: Question – Please Tell Us About The AMEERA-6 Trial   So, I’m talking about AMEERA-6 which is…

Audio: Transcript: INVINCIBLE Trial: INT230-6 Triggers Tumor Necrosis In Vivo – Nicholas Coupe, MBBS @nickcoupe123 @OUHospitals #ASCO22 #OncoTwitter

Non-Small Cell Lung Cancer 3 Mins Read

Audio: Thank you, thanks for the question so this study titled IMP is an early phase dose-escalation study first in…

Melanoma & CD8 Killer T Cells

Non-Small Cell Lung Cancer 7 Mins Read

INT230-6 is an early phase dose-escalation study first in hand study evaluating effectiveness of a new compound called PORT-2 now…

Audio: Transcript: INVINCIBLE Trial: INT230-6 Triggers Tumor Necrosis In Vivo – Nicholas Coupe, MBBS @nickcoupe123 @OUHospitals #ASCO22 #OncoTwitter

Non-Small Cell Lung Cancer 5 Mins Read

  Article: Transcript: Question – Please Tell Us About the INVINCIBLE Trial.   Thank you, thanks for the question so…

Daratumumab + lenalidomide MRD negative status in Griffin Study

Multiple Myeloma 9 Mins Read

The GRIFFIN Study is a post-hoc analysis of sustained MRD negative status in the griffin study which treated patients with…

Audio: What I-SPY2 Data Stands Out for Breast Cancer? – Laura Ann Huppert, MD @laura_huppert @hoperugo @UCSF #ASCO22 #OncoTwitter

Breast Cancer 2 Mins Read

Audio: So the I-SPY2 trial is a neoadjuvant phase 2 study that enrolls patients with any type of breast cancer…

Pathologic Complete Response: How may the I-SPY2 trial help HR positive HER2 negative Breast Cancer patients? Laura Huppert

Breast Cancer 10 Mins Read

Pathologic Complete Response: How may the I-SPY2 trial help HR positive HER2 negative Breast Cancer patients? Laura Huppert By Laura…

Article: Transcript: What I-SPY2 Data Stands Out for Breast Cancer? – Laura Ann Huppert, MD @laura_huppert @hoperugo @UCSF #ASCO22 #OncoTwitter

Breast Cancer 5 Mins Read

Transcript: So the I-SPY2  trial is a neoadjuvant phase 2 study that enrolls patients with any type of breast cancer…

Audio: MASTERKEY-115: A Complete (But Concise) Update for Melanoma Treatment – Brian Gastman, MD @BrianGastmanMD @GastmanLab @CleClinicLCM #ASCO22 #OncoTwitter

Melanoma Skin Cancer Treatment 2 Mins Read

Audio: The FDA approval of multiple drugs um for the treatment of metastatic unresectable melanoma led to uh the concept…

T-Vec: + Pembro Advanced Melanoma MASTERKEY-115 Trial Dr Gastman

Melanoma Skin Cancer Treatment 14 Mins Read

T-Vec: + Pembro Advanced Melanoma MASTERKEY-115 Trial Dr Gastman By Brian Gastman, MD The FDA’s approval of multiple drugs for…

Article: Transcript: MASTERKEY-115: A Complete (But Concise) Update for Melanoma Treatment – Brian Gastman, MD @BrianGastmanMD @GastmanLab @CleClinicLCM #ASCO22 #OncoTwitter

Melanoma Skin Cancer Treatment 11 Mins Read

Transcript: The FDA approval of multiple drugs for the treatment of metastatic unresectable melanoma led to the concept that we…

Audio: Targeting K-RAS in Lung Cancer is a Goliath Task (But We Have Some Answers) – Jia Luo, MD @Jia_Luo @DanaFarber @harvardmed #ASCO22 #OncoTwitter

Non-Small Cell Lung Cancer 1 Min Read

Audio: Hi there my name is Jia Luo I’m a thoracic medical oncologist at Dana-Farber it’s very nice to speak…

KRAS Lung Cancer: Taking on Goliath Discussion by Jai Luo MD

Non-Small Cell Lung Cancer 7 Mins Read

KRAS Lung Cancer: Taking on Goliath Discussion by Jai Luo MD By Jai Luo, MD Hi there, my name is…

Article: Transcript: Targeting K-RAS in Lung Cancer is a Goliath Task (But We Have Some Answers) – Jia Luo, MD @Jia_Luo @DanaFarber @harvardmed #ASCO22 #OncoTwitter

Non-Small Cell Lung Cancer 4 Mins Read

Transcript: Hi there my name is Jia Luo I’m a thoracic medical oncologist at Dana-Farber it’s very nice to speak…

Audio: EV-301 Stats: A Cheat Sheet For Oncologists Treating Urothelial Cancer – Jonathan E. Rosenberg, MD @DrRosenbergMSK @MSKCancerCenter @AstellasUS @Seagen #ASCO22 #Onc…

Breast Cancer 2 Mins Read

Audio: Enfortumab Vedotin was tested in a randomized phase 3 trial in patients with metastatic urothelial cancer who had previously…

EV-301 Stats: A Cheat Sheet For Oncologists: Urothelial Cancer

Breast Cancer 2 Mins Read

Video: Enfortumab Vedotin was tested in a randomized phase 3 trial in patients with metastatic urothelial cancer who had previously…

Article: Transcript: EV-301 Stats: A Cheat Sheet for Oncologists Treating Urothelial Cancer – Jonathan E. Rosenberg, MD @DrRosenbergMSK @MSKCancerCenter @AstellasUS @Seage…

Kidney 7 Mins Read

Enfortumab Vedotin was tested in a randomized phase 3 trial in patients with metastatic urothelial cancer who had previously received…

Article: Transcript: KEYNOTE-716 New Facts You Need To Know – Professor Georgina Long @ProfGLongMIA @MelanomaAus @SydCancerNetwork @NthSydHealth #ASCO22 #OncoTwitter

Melanoma Skin Cancer Treatment 7 Mins Read

Transcript – KEYNOTE-716 New Facts You Need To Know – Article Question – Please Tell Us About The KEYNOTE-716 Study.…

Article: Transcript: Where is the Elaine 2 Study and Just-in-Time Model Right Now? – Halle Moore, MD @HalleMooreMD @CleClinicMD @SWOGOnc #ASCO22 #OncoTwitter

Breast Cancer 4 Mins Read

Transcript – Where is the Elaine 2 Study and Just-in-time Model Right Now? – Article Question – Please Tell Us…

Audio: Where is the Elaine 2 Study and Just-in-Time Model Right Now? – Halle Moore, MD @HalleMooreMD @CleClinicMD @SWOGOnc #ASCO22 #OncoTwitter

Breast Cancer 1 Min Read

Audio: Open label phase 2 multi-center study looking at Lasofoxifene (LAS) in combination with a Abemaciclib (Abema) for treating postmenopausal…

Video: Where is the Elaine 2 Study and Just-in-Time Model Right Now? – Halle Moore, MD @HalleMooreMD @CleClinicMD @SWOGOnc #ASCO22 #OncoTwitter

Breast Cancer 1 Min Read

Video: Open label phase 2 multi-center study looking at Lasofoxifene (LAS) in combination with a Abemaciclib (Abema) for treating postmenopausal…

Podcast Chirag Shah, MD @CShahMD @ClevelandClinic @WhitworthMD @RRabinovitch @margenthalerj ASCO22 #OncoTwitter @oncoalert Assessing The Benefit Of AET

Breast Cancer 1 Min Read

Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at…

DCISionRT: Assessing Breast Cancer Adjuvant Endocrine Therapy After BCS Chirag Shah MD

Breast Cancer 9 Mins Read

DCISionRT: Assessing Breast Cancer Adjuvant Endocrine Therapy After BCS Chirag Shah MD By Chirag Shah, MD So this study was…

Podcast Aaron T. Gerds, MD @AaronGerds @CleClinicMD #EHA22 #OncoTwitter REVEAL Trial

Hematologic Malignancies 4 Mins Read

Aaron T. Gerds, MD, MS, Associate Professor of Medicine, Deputy Director for Clinical Research at the Cleveland Clinic Taussig Cancer…

Hematocrit & Thrombosis Risk in Polycythemia Vera

Hematologic Malignancies 7 Mins Read

At this year’s EHA meeting, we presented an abstract from the REVEAL study. Really focusing in on thrombosis risk in…

Podcast Hang Quach, MD @HangQuach1 @Haem_pmcc_rmh @StVHealthAust #EHA22 #OncoTwitter @oncoalert Phase III CANDOR Study

Multiple Myeloma 4 Mins Read

Hang Quach, MBBS(Hons), SpecCertOC, FRACP, FRCPA, MD, Haematologist with clinical and research interests in multiple myeloma, in particular myeloma, lymphoma…

Multiple Myeloma Dexamethasone, Daratumumab, Carfilzomib Phase 3 Data

Multiple Myeloma 8 Mins Read

The study that I will be discussing today is the frailty subgroup analysis of the CANDOR study, which is a…

Podcast Aaron T. Gerds, MD @AaronGerds @CleClinicMD #EHA22 #OncoTwitter Phase III MOMENTUM Trial

Myeloproliferative Disease 3 Mins Read

Aaron T. Gerds, MD, MS, Associate Professor of Medicine, Deputy Director for Clinical Research at the Cleveland Clinic Taussig Cancer…

Momelotinib a JAK inhibitor vs Danazol in Myelofibrosis

Myeloproliferative Disease 14 Mins Read

Momelotinib Shows Promising JAK and ALK2 Inhabitation in Patients With Anemic Myelofibrosis: MOMENTUM Study It’s my pleasure today to discuss…

Podcast Prof. Peter Hillmen @UniversityLeeds #EHA22 #OncoTwitter @oncoalert Phase III FLAIR Study

Chronic Lymphocytic Leukemia 4 Mins Read

Professor Peter Hillmen, MD, he leads the Experimental Haematology section in LICAP and the Translational Haematology Research group. He is…

Is Venetoclax + Ibrutinib better Ibrutinib Monotherapy in CLL?

Chronic Lymphocytic Leukemia 9 Mins Read

So, I presented the interim analysis of the second part of the FLARE trial, which is a randomized phase 3…

Podcast Dana B Cardin, MD @CardinMD @CathyEngMD @VUMCHealth @VUMC_Cancer #OncoTwitter @oncoalert Trends In The Incidence And Treatment Of EOPC

Pancreatic 2 Mins Read

Dana B Cardin, MD, MSCI, Associate Professor of Medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center. In…

Dana B Cardin, MD @CardinMD @CathyEngMD @VUMCHealth @VUMC_Cancer #OncoTwitter @oncoalert Trends In The Incidence And Treatment Of EOPC

Pancreatic 2 Mins Read

Dana B Cardin, MD, MSCI, Associate Professor of Medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center. In…

Podcast Prof Georgina Long @ProfGLongMIA @MelanomaAus @SydCancerNetwork @NthSydHealth #ASCO22 #OncoTwitter @OncoAlert Phase 3 KEYNOTE-716 Study

Melanoma Skin Cancer Treatment 1 Min Read

Professor Georgina V. Long, MD, PhD, FRACP, Chair of Melanoma Medical Oncology &Translational Research, Translational Node, Faculty of Medicine and…

Prof Georgina Long @ProfGLongMIA @MelanomaAus @SydCancerNetwork @NthSydHealth #ASCO22 #OncoTwitter @OncoAlert Phase 3 KEYNOTE-716 Study

Melanoma Skin Cancer Treatment 1 Min Read

Professor Georgina V. Long, MD, PhD, FRACP, Chair of Melanoma Medical Oncology &Translational Research, Translational Node, Faculty of Medicine and…

Podcast Cynthia X. Ma, MD @WUSTL #ASCO22 #OncoTwitter @oncoalert FLEX Registry Study

Breast Cancer 1 Min Read

Cynthia X. Ma, MD, Professor, Department of Medicine, Oncology Division of Medial Oncology of Washington University School of Medicine. In…

Cynthia X. Ma, MD @WUSTL #ASCO22 #OncoTwitter @oncoalert FLEX Registry Study

Breast Cancer 1 Min Read

Cynthia X. Ma, MD, Professor, Department of Medicine, Oncology Division of Medial Oncology of Washington University School of Medicine. In…

Podcast Angel Arnaout, MD @OttawaHospital @uOttawa #ASCO22 #OncoTwitter @OncoAlert Phase 2 INVINCIBLE Study

Breast Cancer 1 Min Read

Angel Arnaout, MD, MSc, FRCSC, FACS, Regional Director of Breast Surgical Oncology, part of the Ottawa Breast Cancer Biomarker Research…

Angel Arnaout, MD @OttawaHospital @uOttawa #ASCO22 #OncoTwitter @OncoAlert Phase 2 INVINCIBLE Study

Breast Cancer 1 Min Read

Angel Arnaout, MD, MSc, FRCSC, FACS, Regional Director of Breast Surgical Oncology, part of the Ottawa Breast Cancer Biomarker Research…

Podcast Charles Ricordel, MD @C_Ricordel @CHURennes @UnivRennes1 #ASCO22 #OncoTwitter @oncoalert Phase 1/2 CEACAM5 Study

Non-Small Cell Lung Cancer 1 Min Read

Charles Ricordel, MD, PhD, Thoracic Oncologist at CHU de Rennes. In this audio, he speaks about the ASCO 2022 Abstract…

CEACAM5: Safety and Efficacy Outcome in Long-term Treatment with SAR408701 in Pts with NSQ NSCLC Prof Charles Ricordel

Non-Small Cell Lung Cancer 10 Mins Read

CEACAM5: Safety and Efficacy Outcome in Long-term Treatment with SAR408701 in Pts with NSQ NSCLC Prof Charles Ricordel By Professor…

Podcast Heinz-Josef Lenz, MD @uscnorris @USC @KeckMedUSC @SWOG #ASCO22 #OncoTwitter @OncoAlert Randomized Phase III Trial In Pts With MCC

Colorectal 3 Mins Read

Heinz-Josef Lenz, MD, is a professor in the Departments of Medicine and Preventive Medicine in Keck School of Medicine’s oncology…

Heinz-Josef Lenz, MD @uscnorris @USC @KeckMedUSC @SWOG #ASCO22 #OncoTwitter @OncoAlert Randomized Phase III Trial In Pts With MCC

Colorectal 3 Mins Read

Heinz-Josef Lenz, MD, is a professor in the Departments of Medicine and Preventive Medicine in Keck School of Medicine’s oncology…

Podcast Erika Hamilton, MD @ErikaHamilton9 @SarahCannonDocs #OncoTwitter @OncoAlert Safety Update: DESTINY-Breast03 Phase III Trial

Breast Cancer 2 Mins Read

Erika Hamilton, MD, Director, Breast Cancer and Gynecologic Cancer Research Program; Principal Investigator at Sarah Cannon Research Institute. In this…

Erika Hamilton, MD @ErikaHamilton9 @SarahCannonDocs #OncoTwitter @OncoAlert Safety Update: DESTINY-Breast03 Phase III Trial

Breast Cancer 2 Mins Read

Erika Hamilton, MD, Director, Breast Cancer and Gynecologic Cancer Research Program; Principal Investigator at Sarah Cannon Research Institute. In this…

Podcast Jonathan Zager, MD @jzager99 @MoffittNews #ASCO22 #OncoTwitter @oncoalert Phase III FOCUS Trial

Melanoma Skin Cancer Treatment 1 Min Read

Jonathan Zager, MD, Chief Academic Officer, Chair, USF Department of Oncologic Sciences at Moffitt Cancer Center. In this audio, he…

Jonathan Zager, MD @jzager99 @MoffittNews #ASCO22 #OncoTwitter @oncoalert Phase III FOCUS Trial

Melanoma Skin Cancer Treatment 1 Min Read

Jonathan Zager, MD, Chief Academic Officer, Chair, USF Department of Oncologic Sciences at Moffitt Cancer Center. In this video, he…

Podcast Thomas George, MD @TGeorgeMD @UFHealthCancer @NSABPFoundation @HH_Oncodr @CaioRLOnc @jcfabregas @aakonc @GregYothers @NateraGenetics @Novartis #ASCO22 #OncoTwitter @oncoalert #ASC…

Colorectal 3 Mins Read

Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this audio, he speaks about the ASCO 2022…

Thomas George, MD @TGeorgeMD @UFHealthCancer @NSABPFoundation @HH_Oncodr @CaioRLOnc @jcfabregas @aakonc @GregYothers @NateraGenetics @Novartis #ASCO22 #OncoTwitter @oncoalert #ASCO22 #Onc…

Colorectal 3 Mins Read

Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this video, he speaks about the ASCO 2022…

Podcast Trevor M. Feinstein, MD #PiedmontCancerInstitute #ASCO22 #OncoTwitter @oncoalert DUBLIN-3 Phase III Study

Non-Small Cell Lung Cancer 5 Mins Read

Trevor M. Feinstein, MD, Oncologist, Hematologist at Piedmont Cancer Institute. In this audio, he speaks about the ASCO 2022 Abstract…

Plinabulin Improved OS lower Toxicity in NSCLC EGFR

Non-Small Cell Lung Cancer 13 Mins Read

Plinabulin Improved OS and lower Toxicity in NSCLC EGFR Wild Type The DUBLIN-3 was a randomized phase III trial from…

Podcast Douglas W. Blayney, MD @BlayneyDouglas @StanfordMed @BeyondSpringInc #ASCO22 #OncoTwitter @oncoalert Phase 3 Real-world Effectiveness Of G-CSF In Pts with BC

Breast Cancer 1 Min Read

Douglas W. Blayney, MD, FASCO, Clinical researcher and breast oncologist, Professor of Medicine at Stanford University. In this audio, he…

Douglas W. Blayney, MD @BlayneyDouglas @StanfordMed @BeyondSpringInc #ASCO22 #OncoTwitter @oncoalert Phase 3 Real-world Effectiveness Of G-CSF In Pts with BC

Breast Cancer 1 Min Read

Douglas W. Blayney, MD, FASCO, Clinical researcher and breast oncologist, Professor of Medicine at Stanford University. In this video, he…

Podcast Debra A. Patt, MD @dapattmd @TexasOncology @TheUSOnetwork #ASCO22 #OncoTwitter @oncoalert Analyzing Pt Engagement With Digital Health Tools

Breast Cancer 1 Min Read

Debra A. Patt, MD, Ph.D., MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an…

Debra A. Patt, MD @dapattmd @TexasOncology @TheUSOnetwork #ASCO22 #OncoTwitter @oncoalert Analyzing Pt Engagement With Digital Health Tools

Breast Cancer 1 Min Read

Debra A. Patt, MD, Ph.D., MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an…

Podcast Ping Ye, PhD @TheUSONetwork #ASCO22 #OncoTwitter @oncoalert Initial Outcome Of Deploying A Mortality Prediction Tool

Other 1 Min Read

Ping Ye, Ph.D., a senior data scientist for the U.S. Oncology Network, and McKesson. In this audio, she speaks about…

Ping Ye, PhD @TheUSONetwork #ASCO22 #OncoTwitter @oncoalert Initial Outcome Of Deploying A Mortality Prediction Tool

Other 1 Min Read

Ping Ye, Ph.D., a senior data scientist for the U.S. Oncology Network, and McKesson. In this video, she speaks about…

Podcast Mark T. Fleming, MD @MarkTFlemingMD1 @TheUSONetwork #ASCO22 #OncoTwitter @oncoalert Impact Of Diversity, Equity, And Inclusion Training

Other 1 Min Read

Mark T. Fleming, MD is a board-certified medical oncologist. He earned his B.A. from the famous University of Pennsylvania in…

Mark T. Fleming, MD @MarkTFlemingMD1 @TheUSONetwork #ASCO22 #OncoTwitter @oncoalert Impact Of Diversity, Equity, And Inclusion Training

Other 1 Min Read

Mark T. Fleming, MD is a board-certified medical oncologist. He earned his B.A. from the famous University of Pennsylvania in…

Podcast Gabriela Chiosis, PhD @GabrielaChiosis @chiosislabmskcc @MSKCancerCenter #OncoTwitter @oncoalert Synthesis Of 124I-labeled Epichaperome Probes

Other 2 Mins Read

Audio: So I’m Dr. Gabriel Chiosis. I’m a professor and member at Sloan-Kettering Cancer Center and I’m going to discuss…

Epichaperome Probes Synthesis of 124I-labeled

Other 12 Mins Read

Protocol Synthesis of 124I-labeled epichaperome probes and assessment in visualizing pathologic protein-protein interaction networks I’m going to discuss today our…

Podcast Richard Kim, MD @MoffittNews #ASCO22 #OncoTwitter @oncoalert KEYNOTE-651 Long-Term Follow-Up

Colorectal 1 Min Read

Richard Kim, MD, Professor, clinical and research interests focus on gastrointestinal tumors, in particular, hepatobiliary and colon cancer at Moffitt…

Richard Kim, MD @MoffittNews #ASCO22 #OncoTwitter @oncoalert KEYNOTE-651 Long-Term Follow-Up

Colorectal 1 Min Read

Richard Kim, MD, Professor, clinical and research interests focus on gastrointestinal tumors, in particular, hepatobiliary and colon cancer at Moffitt…

Podcast Andrea Bocobo, BS @agbocobo @UCSFCancer @WeAreTouro #ASCO22 #OncoTwitter @oncoalert Phase II Study for Pts with MMS mCRC

Colorectal 1 Min Read

Andrea Grace Bocobo, BS, Fourth-year medical student at Touro University California and Visiting Graduate Student at UCSF GI Oncology. In…

Andrea Bocobo, BS @agbocobo @UCSFCancer @WeAreTouro #ASCO22 #OncoTwitter @oncoalert Phase II Study for Pts with MMS mCRC

Colorectal 1 Min Read

Andrea Grace Bocobo, BS, Fourth-year medical student at Touro University California and Visiting Graduate Student at UCSF GI Oncology. In…

Podcast Abhishek Tripathi, MD @AbhiTrip87 @OUHealth @StephensonCC #ASCO22 #OncoTwitter @oncoalert Phase III CHAARTED Trial

Prostate Cancer Treatment 1 Min Read

Abhishek Tripathi, MD, Assistant Professor of Medicine in the section of Hematology/Oncology at the University Of Oklahoma Health Sciences Center.…

Abhishek Tripathi, MD @AbhiTrip87 @OUHealth @StephensonCC #ASCO22 #OncoTwitter @oncoalert Phase III CHAARTED Trial

Prostate Cancer Treatment 1 Min Read

Abhishek Tripathi, MD, Assistant Professor of Medicine in the section of Hematology/Oncology at the University Of Oklahoma Health Sciences Center.…

Podcast Bijal Shah, MD @MoffittNews #ASCO22 #OncoTwitter @oncoalert ZUMA-3 Study: Two-year Follow-up

Other 1 Min Read

Bijal Shah, MD, MS, is an Associate Member in the Department of Malignant Hematology at Moffitt Cancer Center. In this…

Bijal Shah, MD @MoffittNews #ASCO22 #OncoTwitter @oncoalert ZUMA-3 Study: Two-year Follow-up

Other 1 Min Read

Bijal Shah, MD, MS, is an Associate Member in the Department of Malignant Hematology at Moffitt Cancer Center. In this…

Podcast Robert Ferguson, PhD @upmc @IUMedSchool #ASCO22 #OncoTwitter @oncoalert TAMS Study For Cognitive Impairment

Other 1 Min Read

Robert Ferguson, Ph.D., Biobehavioral Cancer Control Program at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.…

Robert Ferguson, PhD @upmc @IUMedSchool #ASCO22 #OncoTwitter @oncoalert TAMS Study For Cognitive Impairment

Other 1 Min Read

Robert Ferguson, Ph.D., Biobehavioral Cancer Control Program at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.…

Podcast Ruben A. Mesa, MD @mpdrc @UTHealthSAMDA #ASCO22 #OncoTwitter @oncoalert Phase III MOMENTUM Study

Bone Metastases 3 Mins Read

Ruben Mesa, MD, FACP, Executive Director of the Mays Cancer Center, home to UT Health San Antonio, MD Anderson Cancer…

Ruben A. Mesa, MD @mpdrc @UTHealthSAMDA #ASCO22 #OncoTwitter @oncoalert Phase III MOMENTUM Study

Bone Metastases 3 Mins Read

Ruben Mesa, MD, FACP, Executive Director of the Mays Cancer Center, home to UT Health San Antonio, MD Anderson Cancer…

Podcast Richard Woodman, MD @EisaiUS #ASCO22 #OncoTwitter Phase 3 KEYNOTE-775 309 Study

Uterine 3 Mins Read

Richard Woodman, MD Chief Clinical Officer, Oncology Business Group at Eisai, Inc.. In this video, he speaks about the ASCO…

Richard Woodman, MD @EisaiUS #ASCO22 #OncoTwitter Phase 3 KEYNOTE-775 309 Study

Uterine 3 Mins Read

Richard Woodman, MD Chief Clinical Officer, Oncology Business Group at Eisai, Inc.. In this video, he speaks about the ASCO…

Podcast Rebecca S. Kristeleit, MD @RKristeleit @GSTTresearch #ASCO22 #OncoTwitter Phase III ATHENA-MONO ASCO Late Breaker

Ovarian 1 Min Read

Rebecca S. Kristeleit, MD, Ph.D., FRCP, specialises in the treatment of gynaecological cancers including cervical, endometrial and ovarian cancer. She…

Rebecca S. Kristeleit, MD @RKristeleit @GSTTresearch #ASCO22 #OncoTwitter Phase III ATHENA-MONO ASCO Late Breaker

Ovarian 1 Min Read

Rebecca S. Kristeleit, MD, Ph.D., FRCP, specialises in the treatment of gynaecological cancers including cervical, endometrial and ovarian cancer. She…

Podcast Howard M. Sandler, MD @DrHowardSandler @CedarsSinai #ASCO22 #OncoTwitter Phase III ATLAS Trial

Prostate Cancer Treatment 3 Mins Read

Howard M. Sandler, MD, Ronald H. Bloom Family Chair, Cancer Therapeutics, Chair, Department of Radiation Oncology, Professor, Radiation Oncology at…

Howard M. Sandler, MD @DrHowardSandler @CedarsSinai #ASCO22 #OncoTwitter Phase III ATLAS Trial

Prostate Cancer Treatment 3 Mins Read

Howard M. Sandler, MD, Ronald H. Bloom Family Chair, Cancer Therapeutics, Chair, Department of Radiation Oncology, Professor, Radiation Oncology at…

Podcast Michael B. Atkins, MD @Georgetown @LombardiCancer @eaonc #ASCO22 #OncoTwitter DREAMseq Phase III Study

Multiple Myeloma 3 Mins Read

Michael B. Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, William M. Scholl Professor and Vice-Chair Department of Oncology and…

Michael B. Atkins, MD @Georgetown @LombardiCancer @eaonc #ASCO22 #OncoTwitter DREAMseq Phase III Study

Multiple Myeloma 3 Mins Read

Michael B. Atkins, MD, Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center, William M. Scholl Professor and Vice-Chair Department of Oncology and…

Podcast Diwakar Davar, MBBS, M.Sc @diwakardavar @upmc #ASCO22 #OncoTwitter Dose Escalation – NEON-1 Study

Other 3 Mins Read

Diwakar Davar, MBBS, M.Sc, Assistant Professor, Phase I Therapeutics and Melanoma at UPMC. In this video, he speaks about the…

Diwakar Davar, MBBS, M.Sc @diwakardavar @upmc #ASCO22 #OncoTwitter Dose Escalation – NEON-1 Study

Other 3 Mins Read

Diwakar Davar, MBBS, M.Sc, Assistant Professor, Phase I Therapeutics and Melanoma at UPMC. In this video, he speaks about the…

Podcast Richard Woodman, MD @EisaiUS #ASCO22 #OncoTwitter Phase 3 CLEAR 307 Study

Kidney 3 Mins Read

Richard Woodman, MD Chief Clinical Officer, Oncology Business Group at Eisai, Inc.. In this video, he speaks about the ASCO…

Richard Woodman, MD @EisaiUS #ASCO22 #OncoTwitter Phase 3 CLEAR 307 Study

Kidney 3 Mins Read

Richard Woodman, MD Chief Clinical Officer, Oncology Business Group at Eisai, Inc.. In this video, he speaks about the ASCO…

Podcast Mary O’Brien, MD @drMaryOBr @royalmarsdenNHS #ASCO22 #OncoTwitter Phase III PEARLS/KEYNOTE-091 Discussion

Non-Small Cell Lung Cancer 3 Mins Read

Professor Mary O’Brien, Consultant Medical Oncologist MD FRCP at The Royal Marsden NHS Foundation Trust (RHM), Professor of practice (medical…

Mary O’Brien, MD @drMaryOBr @royalmarsdenNHS #ASCO22 #OncoTwitter Phase III PEARLS/KEYNOTE-091 Discussion

Non-Small Cell Lung Cancer 3 Mins Read

Professor Mary O’Brien, Consultant Medical Oncologist MD FRCP at The Royal Marsden NHS Foundation Trust (RHM), Professor of practice (medical…

Podcast Steven Ansell, MD @MayoClinic #ASCO22 #OncoTwitter @oncoalert Phase III ECHELON-1 Study

Hodgkin Lymphoma 3 Mins Read

Steven Ansell, MD, PhD, Professor of Medicine at Mayo Clinic. In this video, he speaks about the ASCO Abstract -…

Brentuximab Vedotin ABVD Hodgkin’s Lymphoma Phase 3 Data

Hodgkin Lymphoma 8 Mins Read

The clinical trial that we are discussing is Echelon-1. This is a study specifically for patients with advanced-stage Hodgkin’s lymphoma…

Podcast Ian Krop, MD @YaleGICancers @YaleCancer #ASCO22 #OncoTwitter @oncoalert HER2CLIMB-04 Phase 2 Study

Breast Cancer 3 Mins Read

Ian Krop, MD, Ph.D., Associate Cancer Center Director for Clinical Research; Yale Cancer Center. In this video, he speaks about…

Ian Krop, MD @YaleGICancers @YaleCancer #ASCO22 #OncoTwitter @oncoalert HER2CLIMB-04 Phase 2 Study

Breast Cancer 3 Mins Read

Ian Krop, MD, Ph.D., Associate Cancer Center Director for Clinical Research; Yale Cancer Center. In this video, he speaks about…

Podcast Thomas Hope, MD @thomashopemd @UCSF @SFVAMC #ASCO22 #OncoTwitter Imaging of solid tumors using 68Ga-FAP-2286

Imaging 3 Mins Read

Thomas Hope, MD, Associate Professor in Residence at UC San Francisco. In this video, he speaks about the ASCO 2022…

Thomas Hope, MD @thomashopemd @UCSF @SFVAMC #ASCO22 #OncoTwitter Imaging of solid tumors using 68Ga-FAP-2286

Imaging 3 Mins Read

Thomas Hope, MD, Associate Professor in Residence at UC San Francisco. In this video, he speaks about the ASCO 2022…

Podcast Pamela Kunz, MD @PamelaKunzMD @YaleGICancers @DrHendifar @DianeReidyLagun #ASCO22 #OncoTwitter Final Analysis: ECOG-ACRIN E2211

Pancreatic 3 Mins Read

Pamela Kunz, MD, Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and…

Pamela Kunz, MD @PamelaKunzMD @YaleGICancers @DrHendifar @DianeReidyLagun #ASCO22 #OncoTwitter Final Analysis: ECOG-ACRIN E2211

Pancreatic 3 Mins Read

Pamela Kunz, MD, Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and…

Podcast Matthew J. Frigault, MD @MJFzeta @MGHCancerCenter #ASCO22 #OncoTwitter CART-ddBCMA in RRMM

Multiple Myeloma 3 Mins Read

Matthew J. Frigault, MD, Clinical Director- Cellular Immunotherapy Program at Mass General Cancer Center. In this video, he speaks about…

Matthew J. Frigault, MD @MJFzeta @MGHCancerCenter #ASCO22 #OncoTwitter CART-ddBCMA in RRMM

Multiple Myeloma 3 Mins Read

Matthew J. Frigault, MD, Clinical Director- Cellular Immunotherapy Program at Mass General Cancer Center. In this video, he speaks about…

Podcast Nima Sharifi, MD @NimaSharifiMD @MehdiBaratchian @ritika0107 @CleClinicMD #OncoTwitter H3K9 Methylation In Prostate Cancer

Pancreatic 2 Mins Read

Nima Sharifi, MD, director, Center for GU Malignancies Research, Lerner Research Institute, Cleveland Clinic. In this video, he speaks about…

Nima Sharifi, MD @NimaSharifiMD @MehdiBaratchian @ritika0107 @CleClinicMD #OncoTwitter H3K9 Methylation In Prostate Cancer

Pancreatic 2 Mins Read

Nima Sharifi, MD, director, Center for GU Malignancies Research, Lerner Research Institute, Cleveland Clinic. In this video, he speaks about…

Podcast Min Sun, MD @cancerdocms @xlu29466 @upmc #ASCO22 #OncoTwitter Phase 3 Studies Testing of a ML Model

Colorectal 2 Mins Read

Min Sun, MD, Ph.D., Oncologist, and Hematologist at UPMC Hillman Cancer Center, Clinical Assistant Professor at the University of Pittsburgh…

Min Sun, MD @cancerdocms @xlu29466 @upmc #ASCO22 #OncoTwitter Phase 3 Studies Testing of a ML Model

Colorectal 2 Mins Read

Min Sun, MD, Ph.D., Oncologist, and Hematologist at UPMC Hillman Cancer Center, Clinical Assistant Professor at the University of Pittsburgh…

Podcast Nageshwara Dasari, MD @adasarimd @MDAndersonNews #ASCO22 @oncoalert CIRCULATE-US Phase 2, Phase 3 Trail

Colorectal 2 Mins Read

Nageshwara Arvind Dasari, MD, Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine at MD Anderson Cancer…

Nageshwara Dasari, MD @adasarimd @MDAndersonNews #ASCO22 @oncoalert CIRCULATE-US Phase 2, Phase 3 Trail

Colorectal 2 Mins Read

Nageshwara Arvind Dasari, MD, Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine at MD Anderson Cancer…

Podcast Elyse Park, PhD @PsycholERPark @MGH_HPRIR @AmericanCancer @MassGeneralNews #ASCO22 #OncoTwitter The Childhood Cancer Survivor Study

Other 1 Min Read

Elyse R. Park, Ph.D., MSPH, Associate Director of the MGH Survivorship Program & I direct the MGH Medicine/Psychiatry HPRIR program,…

Elyse Park, PhD @PsycholERPark @MGH_HPRIR @AmericanCancer @MassGeneralNews #ASCO22 #OncoTwitter The Childhood Cancer Survivor Study

Other 1 Min Read

Elyse R. Park, Ph.D., MSPH, Associate Director of the MGH Survivorship Program & I direct the MGH Medicine/Psychiatry HPRIR program,…

Podcast Sue Yom, MD @sueyom @UCSFCancer #ASCO22 #NGR #OncoTwitter Translational analysis from NRG-HN002

Colorectal 3 Mins Read

Sue S. Yom, MD, Ph.D., Professor and Vice Chair, Strategic AdvisoryDepartment of Radiation Oncology; Professor, Otolaryngology-Head and Neck Surgery at…

Sue Yom, MD @sueyom @UCSFCancer #ASCO22 #NGR #OncoTwitter Translational analysis from NRG-HN002

Colorectal 3 Mins Read

Sue S. Yom, MD, Ph.D., Professor and Vice Chair, Strategic AdvisoryDepartment of Radiation Oncology; Professor, Otolaryngology-Head and Neck Surgery at…

Podcast Toni Choueiri, MD @DrChoueiri @df_hcc @DanaFarbernews #ASCO22 #OncoTwitter Phase III KEYNOTE-564 Follow-Up

Kidney 3 Mins Read

Toni Choueiri, MD, Director, Lank Center for Genitourinary Oncology, Director, Kidney Cancer Center, Senior Physician, Jerome and Nancy Kohlberg Chair…

Toni Choueiri, MD @DrChoueiri @df_hcc @DanaFarbernews #ASCO22 #OncoTwitter Phase III KEYNOTE-564 Follow-Up

Kidney 3 Mins Read

Toni Choueiri, MD, Director, Lank Center for Genitourinary Oncology, Director, Kidney Cancer Center, Senior Physician, Jerome and Nancy Kohlberg Chair…

Podcast Roger Li, MD @UrogerliMD @MoffitNews #ASCO22 #OncoTwitter CORE1 Phase 2 Study

Bladder 3 Mins Read

Roger Li, MD, Genitourinary Oncologist at Moffitt Cancer Center. In this video, he speaks about ASCO 2022 abstract CORE1: Phase…

Roger Li, MD @UrogerliMD @MoffitNews #ASCO22 #OncoTwitter CORE1 Phase 2 Study

Bladder 3 Mins Read

Roger Li, MD, Genitourinary Oncologist at Moffitt Cancer Center. In this video, he speaks about ASCO 2022 abstract CORE1: Phase…

Podcast Doris Hansen, MD @SurbhiSidanaMD @DrKrinaPatel @DrFredLocke @MoffittNews #ASCO22 #OncoTwitter Ide-cel CAR For RRMM

Multiple Myeloma 3 Mins Read

Doris Hansen, MD, Assistant Member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy at…

Doris Hansen, MD @SurbhiSidanaMD @DrKrinaPatel @DrFredLocke @MoffittNews #ASCO22 #OncoTwitter Ide-cel CAR For RRMM

Multiple Myeloma 3 Mins Read

Doris Hansen, MD, Assistant Member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy at…

Podcast Dr. Cecchini @Cecchini_OncMD @PamelaKunzMD @YaleGICancers @YaleCancer #ASCO22 #OncoTwitter Molecular Char Of ACC And Multi-Hit PIK3CA

Colorectal 1 Min Read

Michael Cecchini, MD, Assistant Professor of Medicine (Medical Oncology); Co-Director, Colorectal Program in the Center for Gastrointestinal Cancers at Yale…

Dr. Cecchini @Cecchini_OncMD @PamelaKunzMD @YaleGICancers @YaleCancer #ASCO22 #OncoTwitter Molecular Char Of ACC And Multi-Hit PIK3CA

Colorectal 1 Min Read

Michael Cecchini, MD, Assistant Professor of Medicine (Medical Oncology); Co-Director, Colorectal Program in the Center for Gastrointestinal Cancers at Yale…

Podcast Roy S. Herbst, MD @DrRoyHerbstYale @YaleCancer #ASCO22 Phase II S1800A Trial

Non-Small Cell Lung Cancer 3 Mins Read

Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Director, Center for Thoracic Cancers;…

Roy S. Herbst, MD @DrRoyHerbstYale @YaleCancer #ASCO22 Phase II S1800A Trial

Non-Small Cell Lung Cancer 3 Mins Read

Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Director, Center for Thoracic Cancers;…

Podcast Sumanta Pal, MD @montypal @cityofhope @cityofhopeoc #ASCO22 #OncoTwitter Results from Cohorts 3, 4, 5 of the COSMIC-021 Study

Urology 3 Mins Read

Sumanta (Monty) Pal, MD, FASCO, Professor, Department of Medical Oncology & Therapeutics Research and Co-director, Kidney Cancer Program at City…

Sumanta Pal, MD @montypal @cityofhope @cityofhopeoc #ASCO22 #OncoTwitter Results from Cohorts 3, 4, 5 of the COSMIC-021 Study

Urology 3 Mins Read

Sumanta (Monty) Pal, MD, FASCO, Professor, Department of Medical Oncology & Therapeutics Research and Co-director, Kidney Cancer Program at City…

Podcast Karim Chamie, MD @UclaUrology #ASCO22 #OncoTwitter Phase 2/3 QUILT-3.032 Trial

Bladder 3 Mins Read

Karim Chamie, MD, Associate Professor of Urology and Society of Urologic Oncology Fellowship Director at UCLA Health. In this video,…

Karim Chamie, MD @UclaUrology #ASCO22 #OncoTwitter Phase 2/3 QUILT-3.032 Trial

Bladder 3 Mins Read

Karim Chamie, MD, Associate Professor of Urology and Society of Urologic Oncology Fellowship Director at UCLA Health. In this video,…

Michael Keens and Stefan Michiels, PhD @keensmike @AnjuSoftware @StefanMichiels @GustaveRoussy Keeping Global Clinical Trials Going With Tech

Other 3 Mins Read

Clinical Data Management Tools Enables Flexibility and ScalabilitySupporting Evolving Oncology Clinical Study Designs   OncologyTube was privileged to feature Mike…

Podcast Aaron Logan, MD @hemedoc @UCSF #ALL @OncoTwitter @hemedoc @UCSF #ALL #OncoTwitter The Treatment Landscape Of ALL

Acute Lymphoblastic Leukemia 1 Min Read

Aaron Logan, MD, Ph.D., Hematologist, Associate Professor of Clinical Medicine at UC San Francisco. In this video, he speaks about…

Aaron Logan, MD @hemedoc @UCSF #ALL @OncoTwitter @hemedoc @UCSF #ALL #OncoTwitter The Treatment Landscape Of ALL

Acute Lymphoblastic Leukemia 1 Min Read

Aaron Logan, MD, Ph.D., Hematologist, Associate Professor of Clinical Medicine at UC San Francisco. In this video, he speaks about…

Podcast Drs. Basourakos, Shoag and Nyame @SBasourakos @jeshoag @yawnyame @uwurology @WCMUrology #AUA22 #OncoTwitter Three Decades of PSA Screening in Black Men

Prostate Cancer Treatment 3 Mins Read

Spyridon Basourakos, MD, Urology Resident 5th year at Weill Cornell Medicine, Jonathan E. Shoag, MD, Adjunct Clinical Assistant Professor of…

Drs. Basourakos, Shoag and Nyame @SBasourakos @jeshoag @yawnyame @uwurology @WCMUrology #AUA22 #OncoTwitter Three Decades of PSA Screening in Black Men

Prostate Cancer Treatment 3 Mins Read

Spyridon Basourakos, MD, Urology Resident 5th year at Weill Cornell Medicine, Jonathan E. Shoag, MD, Adjunct Clinical Assistant Professor of…

Podcast Neeraj Agarwal, MD @neerajaiims @SWOG #OncoTwitter SWOG-1216 Phase III Study

Prostate Cancer Treatment 2 Mins Read

Neeraj Agarwal, MD, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI),…

Neeraj Agarwal, MD @neerajaiims @SWOG #OncoTwitter SWOG-1216 Phase III Study

Prostate Cancer Treatment 2 Mins Read

Neeraj Agarwal, MD, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI),…

EXUMA Biotech’s Subcutaneous CAR-TaNK and In Vivo CAR Cell And Gene Therapy Programs @EXUMABiotech #celltherapy #genetherapy #biotech

Immunotherapy 2 Mins Read

EXUMA Biotech’s VP of Oncology R&D, Dr. Sid Kerkar, Reveals Preclinical Data From Its Subcutaneous CAR-TaNK And In Vivo CAR…

Podcast Maria Soledad Sosa, PhD @soledadsosa80 @IcahnMountSinai @TischCancer @MSSM_DPS_SPA #OncoTwitter Early-Stage Breast Cancer: Can Become A Silent Killer

Breast Cancer 2 Mins Read

Maria Soledad Sosa, Ph.D.,  Assistant Professor of Pharmacological Sciences, and Oncological Sciences, at The Tisch Cancer Institute at Mount Sinai.…

Maria Soledad Sosa, PhD @soledadsosa80 @IcahnMountSinai @TischCancer @MSSM_DPS_SPA #OncoTwitter Early-Stage Breast Cancer: Can Become A Silent Killer

Breast Cancer 2 Mins Read

Maria Soledad Sosa, Ph.D.,  Assistant Professor of Pharmacological Sciences, and Oncological Sciences, at The Tisch Cancer Institute at Mount Sinai.…

Podcast Dennis J. Slamon, MD @UCLA @UCLAJCCC #OncoTwitter Phase III MONALEESA-3 Trial

Breast Cancer 2 Mins Read

Dennis J. Slamon, MD, Director of Clinical/Translational Research, University of California, Los Angeles Jonsson Comprehensive Cancer Center. In this video,…

Dennis J. Slamon, MD @UCLA @UCLAJCCC #OncoTwitter Phase III MONALEESA-3 Trial

Breast Cancer 2 Mins Read

Dennis J. Slamon, MD, Director of Clinical/Translational Research, University of California, Los Angeles Jonsson Comprehensive Cancer Center. In this video,…

Podcast Roy S. Herbst, MD @DrRoyHerbstYale @YaleCancer #NSCLC #COAST Phase II COAST Study

Non-Small Cell Lung Cancer 1 Min Read

Roy S. Herbst, MD, Ph.D., Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Director, Center for Thoracic Cancers;…

Roy S. Herbst, MD @DrRoyHerbstYale @YaleCancer #NSCLC #COAST Phase II COAST Study

Non-Small Cell Lung Cancer 1 Min Read

Roy S. Herbst, MD, Ph.D., Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Director, Center for Thoracic Cancers;…

Podcast James Yarmolinsky, PhD @jamesyrmsk @EpiHazelWood @mrc_ieu #Molecular #BMI #Cancer Identifying Molecular Mediators EC Risk

Other 3 Mins Read

James Yarmolinsky, Ph.D., Research Fellow at the University of Bristol. In this video, he speaks about Identifying molecular mediators of…

James Yarmolinsky, PhD @jamesyrmsk @mrc_ieu @EpiHazelWood #Molecular #BMI #Cancer Identifying Molecular Mediators EC Risk

Other 3 Mins Read

James Yarmolinsky, Ph.D., Research Fellow at the University of Bristol. In this video, he speaks about Identifying molecular mediators of…

Podcast Raja M. Flores, MD @RajaFlores @MountSinaiNYC @TischCancer #FDABan Menthol Cigarette Ban

Lung Cancer Treatment 2 Mins Read

Raja M. Flores, MD, Professor and System Chair, Thoracic Surgery at Icahn School of Medicine at Mount Sinai. In this…

Raja M. Flores, MD @RajaFlores @MountSinaiNYC @TischCancer #FDABan Menthol Cigarette Ban

Lung Cancer Treatment 2 Mins Read

Raja M. Flores, MD, Professor and System Chair, Thoracic Surgery at Icahn School of Medicine at Mount Sinai. In this…

Podcast Cansu Bozkus, PhD @CimenBozkus_C @BhardwajLab @TischCancer @MountSinaiNYC #AACR22 Analyses Of Tumor-Specific T Cells In The Microsatellite

Other 3 Mins Read

Cansu Cimen Bozkus, PhD, Assistant Professor at Icahn School of Medicine at Mount Sinai. In this video, she speaks about…

Cansu Bozkus, PhD @CimenBozkus_C @BhardwajLab @TischCancer @MountSinaiNYC #AACR22 Analyses Of Tumor-Specific T Cells In The Microsatellite

Other 3 Mins Read

Cansu Cimen Bozkus, PhD, Assistant Professor at Icahn School of Medicine at Mount Sinai. In this video, she speaks about…

Podcast Zeina Nahleh, MD @drznahleh @Cancer_CCFla @CleveClinicFL #Biosimilars The Use of Biosimilars in Oncology

Other 1 Min Read

Zeina Nahleh, MD, FACP, Cancer Center Director and Department Chair, Hematology-Oncology at the Cleveland Clinic. In this video, she speaks…

Zeina Nahleh, MD @drznahleh @Cancer_CCFla @CleveClinicFL #Biosimilars The Use of Biosimilars in Oncology

Other 1 Min Read

Zeina Nahleh, MD, FACP, Cancer Center Director and Department Chair, Hematology-Oncology at the Cleveland Clinic. In this video, she speaks…

Podcast Nicole James, PhD @BrownUniversity @womenandinfants #EOC Prognostic Immunologic Signatures In EOC

Ovarian 1 Min Read

Nichole James, Ph.D., Assistant Professor of Obstetrics and Gynecology (Research) at Brown University and Women and Infants Hospital. In this…

Nicole James, PhD @BrownUniversity @womenandinfants #EOC Prognostic Immunologic Signatures In EOC

Ovarian 1 Min Read

Nichole James, Ph.D., Assistant Professor of Obstetrics and Gynecology (Research) at Brown University and Women and Infants Hospital. In this…

Podcast Lajos Pusztai, MD, DPhil @yalemed @yalecancer @SWOG #CCG Cancer Relevance of Human Genes

Other 2 Mins Read

Lajos Pusztai, MD, DPhil, Professor of Medicine, Co-Leader Genetics, Genomics, and Epigenetics Program, Scientific Co-Director of the Center for Breast…

Lajos Pusztai, MD, DPhil @yalemed @yalecancer @SWOG #CCG Cancer Relevance of Human Genes

Other 2 Mins Read

Lajos Pusztai, MD, DPhil, Professor of Medicine, Co-Leader Genetics, Genomics, and Epigenetics Program, Scientific Co-Director of the Center for Breast…

Podcast Sanika Bodas, PhD @unmc #AACR22 #ProstateCancer Understanding Neurophilin2 Upregulation

Prostate Cancer Treatment 3 Mins Read

Sanika Bodas, Ph.D., Ph.D. Student at University of Nebraska Medical Center. In this video, she speaks about the AACR 2022…

Sanika Bodas, PhD @unmc #AACR22 #ProstateCancer Understanding Neurophilin2 Upregulation

Prostate Cancer Treatment 3 Mins Read

Sanika Bodas, Ph.D., Ph.D. Student at University of Nebraska Medical Center. In this video, she speaks about the AACR 2022…

Podcast Claire Rosean, PhD @immunomix @UW #AACR22 #MCC ITI-3000 First-In-Human Trial

Other 2 Mins Read

Claire Rosean, Ph.D., Senior Scientist at Immunomic Therapeutics. In this video, she speaks about the AACR 2022 Abstract – 2052…

Claire Rosean, PhD @immunomix @UW #AACR22 #MCC ITI-3000 First-In-Human Trial

Other 2 Mins Read

Claire Rosean, Ph.D., Senior Scientist at Immunomic Therapeutics. In this video, she speaks about the AACR 2022 Abstract – 2052…

Podcast Linda Kachuri, PhD @Linda_Kachuri @WitteLab @UCSF_Epibiostat @UCSFCancer #AACR22 Genetic Determinants Of PSA Levels

Other 3 Mins Read

Linda Kachuri, PhD, Postdoctoral Scholar, Epidemiology & Biostatistics at UC San Francisco. In this video, she speaks about the AACR…

Linda Kachuri, PhD @Linda_Kachuri @WitteLab @UCSF_Epibiostat @UCSFCancer #AACR22 Genetic Determinants Of PSA Levels

Prostate Cancer Treatment 3 Mins Read

Linda Kachuri, PhD, Postdoctoral Scholar, Epidemiology & Biostatistics at UC San Francisco. In this video, she speaks about the AACR…

In the Driver’s Seat With EGFR: Application of Mutation Testing to Treatment Selection for NSCLC @achlcme #NSCLC

Non-Small Cell Lung Cancer 1 Min Read

This series offers two interactive programs supported by audio and video commentary, where Dr. Justin Gainor and Dr. Maria Arcila…

Case Challenges in Patients With EGFR-Mutant NSCLC @achlcme #NSCLC

Non-Small Cell Lung Cancer 1 Min Read

This series offers two interactive programs supported by audio and video commentary, where Dr. Justin Gainor and Dr. Maria Arcila…

Podcast Mindie H. Nguyen, MD @Stanford @Stanford_GI #HelioLiver #LiverCancer ENCORE Data: HelioLiver For Liver Cancer

Liver 1 Min Read

Mindie H. Nguyen, MD, MAS, Fellow AGAF, Fellow FAASLD, Hepatologist, Transplant hepatologist, Professor of Medicine (Gastroenterology and Hepatology) and, by…

Mindie H. Nguyen, MD @Stanford @Stanford_GI #HelioLiver #LiverCancer ENCORE Data: HelioLiver For Liver Cancer

Liver 1 Min Read

Mindie H. Nguyen, MD, MAS, Fellow AGAF, Fellow FAASLD, Hepatologist, Transplant hepatologist, Professor of Medicine (Gastroenterology and Hepatology) and, by…

Podcast Federico Aucejo, MD @FAucejo @ClevelandClinic @CleClinicMD @SocSurgOnc #CRLM Recipient and Donor Outcomes In Unresectable CLM

Colorectal 1 Min Read

Federico Aucejo, MD, is the Director of the Liver Cancer Program and Surgical Director of the Liver Tumor Clinic in…

Federico Aucejo, MD @FAucejo @ClevelandClinic @CleClinicMD @SocSurgOnc #CRLM Recipient and Donor Outcomes In Unresectable CLM

Colorectal 1 Min Read

Federico Aucejo, MD, is the Director of the Liver Cancer Program and Surgical Director of the Liver Tumor Clinic in…

Podcast Alberto Anel, PhD @unizar #PT112 Mechanistic Insights On PT-112’s Effects On Prostate Cancer Cell Lines

Prostate Cancer Treatment 3 Mins Read

Alberto Anel, Ph.D., Professor of Biochemistry, Department of Biochemistry and Molecular and Cellular Biology, Biochemistry and Molecular Biology Area, Science…

Alberto Anel, PhD @unizar #PT112 Mechanistic Insights On PT-112’s Effects On Prostate Cancer Cell Lines

Prostate Cancer Treatment 3 Mins Read

Alberto Anel, Ph.D., Professor of Biochemistry, Department of Biochemistry and Molecular and Cellular Biology, Biochemistry and Molecular Biology Area, Science…

Podcast Umamaheswar Duvvuri, MD @duvvuri_md @PittTweet @UMPMHillmanCC @OTOPitt @VAPittsburgh @DeptVetAffairs #HNC Malaria Drug Could Help Chemotherapy-Resistant HNC

Head and Neck 2 Mins Read

Umamaheswar Duvvuri, MD, Ph.D., FACS, Professor, Department of Otolaryngology at UPMC and the VA Pittsburg Health System. In this video,…

Umamaheswar Duvvuri, MD @duvvuri_md @PittTweet @UMPMHillmanCC @OTOPitt @VAPittsburgh @DeptVetAffairs #HNC Malaria Drug Could Help Chemotherapy-Resistant HNC

Head and Neck 2 Mins Read

Umamaheswar Duvvuri, MD, Ph.D., FACS, Professor, Department of Otolaryngology at UPMC and the VA Pittsburg Health System. In this video,…

Podcast Sarbajit Mukherjee, MD @Sarbaji85064063 @RoswellPark #AACR22 #ColorectalCancer Phase II Study Evaluating CKM Regimen

Colorectal 3 Mins Read

Sarbajit Mukherjee, MD, MS, Assistant Professor, Gastrointestinal Medical Oncologist at Roswell Park Cancer Institute. In this video, he speaks about…

Sarbajit Mukherjee, MD @Sarbaji85064063 @RoswellPark #AACR22 #ColorectalCancer Phase II Study Evaluating CKM Regimen

Colorectal 3 Mins Read

Sarbajit Mukherjee, MD, MS, Assistant Professor, Gastrointestinal Medical Oncologist at Roswell Park Cancer Institute. In this video, he speaks about…

Podcast Christiane Querfeld, MD @CityofHope #AACR22 #Lymphoma CD47 Blockade Potentiates Against Cutaneous T cell Lymphoma

Lymphoma 2 Mins Read

Christiane Querfeld, M.D., Ph.D., Director, Cutaneous Lymphoma Program, City of Hope. In this video, she speaks about the AACR 2022…

Christiane Querfeld, MD @CityofHope #AACR22 #Lymphoma CD47 Blockade Potentiates Against Cutaneous T cell Lymphoma

Lymphoma 2 Mins Read

Christiane Querfeld, M.D., Ph.D., Director, Cutaneous Lymphoma Program, City of Hope. In this video, she speaks about the AACR 2022…

Podcast Tyler Nielsen, MBioMed @OncocyteCorp #AACR22 #IOScore Confirmatory Study Of The IO Score In mUC Pts

Other 2 Mins Read

Tyler Nielsen, MBioMed, Staff Scientist at Oncocyte Corporation. In this video, he speaks about the AACR 22 Abstract – 1272…

Tyler Nielsen, MBioMed @OncocyteCorp #AACR22 #IOScore Confirmatory Study Of The IO Score In mUC Pts

Other 2 Mins Read

Tyler Nielsen, MBioMed, Staff Scientist at Oncocyte Corporation. In this video, he speaks about the AACR 22 Abstract – 1272…

Podcast Laura Alder, MD @Lauraathome @DukeCancer #AACR22 #BC #LMD #TDXd HER2+ BC LMD Treated With T-DXd

Breast Cancer 2 Mins Read

Laura Alder, MD, Hematology-Oncology Fellow at Duke University Health System. In this video, she speaks about the AACR 2022 Abstract…

Laura Alder, MD @Lauraathome @DukeCancer #AACR22 #BC #LMD #TDXd HER2+ BC LMD Treated With T-DXd

Breast Cancer 2 Mins Read

Laura Alder, MD, Hematology-Oncology Fellow at Duke University Health System. In this video, she speaks about the AACR 2022 Abstract…

Podcast Michael J. Donovan, MD @IcahnMountSinai #AACR22 #BreastCancer #Genomics Automated Breast Cancer Grading Platform With Genomics

Breast Cancer 2 Mins Read

Michael J. Donovan, MD, Ph.D., Research Professor of Pathology, Molecular, and Cell-Based Medicine at Icahn School of Medicine at Mount…

Michael J. Donovan, MD @IcahnMountSinai #AACR22 #BreastCancer #Genomics Automated Breast Cancer Grading Platform With Genomics

Breast Cancer 2 Mins Read

Michael J. Donovan, MD, Ph.D., Research Professor of Pathology, Molecular, and Cell-Based Medicine at Icahn School of Medicine at Mount…

Podcast Jia Xu, PhD @IcahnMountSinai @TischCancer #AACR22 #Cancer Degradation Of AKT Inhibits Tumor Growth

Other 3 Mins Read

Jia Xu, Ph.D., Instructor – Oncological Sciences at Icahn School of Medicine at Mount Sinai. In this video, he speaks…

Jia Xu, PhD @IcahnMountSinai @TischCancer #AACR22 #Cancer Degradation Of AKT Inhibits Tumor Growth

Other 3 Mins Read

Jia Xu, Ph.D., Instructor – Oncological Sciences at Icahn School of Medicine at Mount Sinai. In this video, he speaks…

Podcast Russell Rockne, PhD @rrockne @CityofHope #AACR22 #Radionuclide #CAR-T Mathematical Model: Radionuclide And CAR-T Therapy

Other 3 Mins Read

Russell Rockne, Ph.D., associate professor, Department of Computational and Quantitative Medicine, City of Hope. In this video, he speaks about…

Russell Rockne, PhD @rrockne @CityofHope #AACR22 #Radionuclide #CAR-T Mathematical Model: Radionuclide And CAR-T Therapy

Other 3 Mins Read

Russell Rockne, Ph.D., associate professor, Department of Computational and Quantitative Medicine, City of Hope. In this video, he speaks about…

Podcast Neha Vapiwala, MD @NehaVapiwala @PennMedicine @NEJM #Diversity #Cancer #Research Four Decades: US Medical Faculty Diversity

Other 1 Min Read

Neha Vapiwala, MD, FACR, FASTRO, Professor and Vice Chair of Education, Radiation Oncology, Associate Dean of Admissions, Perelman School of…

Neha Vapiwala, MD @NehaVapiwala @PennMedicine @NEJM #Diversity #Cancer #Research Four Decades: US Medical Faculty Diversity

Other 1 Min Read

Neha Vapiwala, MD, FACR, FASTRO, Professor and Vice Chair of Education, Radiation Oncology, Associate Dean of Admissions, Perelman School of…

Previous 1 … 4 5 6 7 8 … 50 Next
Recent Posts
  • ESMO 2025 Top 10 Breast Cancer Abstracts: 10 Positive Breakthroughs
  • TCR-T Therapy: 49% Risk Cut & 39% Response
  • ESMO 2025 Top 10 Genitourinary Cancer Must-See Abstracts: 78% rPFS Boost Unveiled
  • Immune Checkpoint Inhibitors Myocarditis: 1% Risk, 50% Fatal – UCSF Insights
  • TIL Therapy Breakthroughs for Oncologists and Oncology Professionals
Connect With Us on Social
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
X (Twitter) LinkedIn Facebook YouTube
  • FDA
  • Conferences
    • AACR
    • ASBRS
    • ASCO
    • SABCS
    • ASH
    • ESMO
    • MOASC
    • Upcoming Oncology Conferences
  • Cancers
    • Breast Cancer
    • Prostate Cancer Treatment
    • Lung Cancer Treatment
    • Gastrointestinal Cancer Treatment
    • Melanoma Skin Cancer Treatment
    • Non-Hodgkin Lymphoma
    • Kidney
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Bone Metastases
    • Brain
    • Business Management
    • Cervical
    • Chronic Lymphocytic Leukemia
    • Chronic Myelogenous Leukemia
    • Colorectal
    • COVID-19
    • General
    • Genitourinary
    • Head and Neck
    • Help
    • Hematologic Malignancies
    • Hodgkin Lymphoma
    • Imaging
    • Immunotherapy
    • Liver
    • Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Disease
    • News
    • Non-Small Cell Lung Cancer
    • Other
    • Ovarian
    • Pancreatic
    • Patient Resources
    • Pediatric
    • Sarcoma
    • Sickle Cell
    • Small Cell Lung Cancer
    • Supportive Care
    • Testicular
    • Urology
    • Uterine
  • About
  • Contact
  • Advertise
    • Advertising and Services – Media Kit 2025 – OncologyTube.com
    • Oncology Press Release Distribution
© 2025 Copyright Protected Medicus Networks, Inc. Privacy Policy

Type above and press Enter to search. Press Esc to cancel.